Aanjaneya
Lifecare Begins the Fiscal on a Strong Note, bags coveted “ Asia’s Emerging
Pharmaceutical Company on Innovations Award 2013” at Assocham’s 10th Knowledge
Millennium Summit.
Aanjaneya
Lifecare Selected for the coveted & Prestigious Title for Innovations, Sustainable Corporate Ethical
Practices & Significant Investors Goodwill.
India, New Delhi. January 18th, 2012: Aanjaneya Lifecare Limited, India’s fastest growing
Pharmaceutical Group having a proven track record of delivering consistence performances
engaged in the manufacture of Active Pharmaceutical Ingredients and Finished
Dosage Forms along with delivery of CRAMS has its presence in 60 countries in the fiercely competitive domestic Contract
Manufacturing Market as well as in International market with a significant
leadership market presence in Quinine Salts
manufacturer in the world received a rare distinction of being Asia’s Emerging Pharmaceutical Company on
Innovations at a Assocham Meet today at Vigyan Bhavan in New Delhi presided
by Pranab Mukherjee, The President of India. . Recently, Aanjaneya Lifecare
Limited has got approval to issue Foreign Currency Convertible Bonds to
eligible foreign investors amounting Rs.405 crore, the only pharmaceutical
company where the Indian government has approved 14 proposals of foreign direct
investment amounting to a total of Rs. 1,310.60 crore. Aanjaneya Lifecare is a
focused integrated emerging pharmaceutical company in bulk drugs as well as
finished dosage forms. Recently Aanjaneya Lifecare has bagged two prestigious
awards by being ranked No 2 Industry wise & 9th Position in Asia- Pacific
region at The Global Investor Relations (GIR) Summit Coordinated by KPMG and MZ associates. Organised
byThe Associated Chambers of Commerce and Industry of India
(ASSOCHAM), India's premier apex chamber covers a membership of over 4 lakh
companies and professionals across the country. It was established in 1920 by
promoter chambers, representing all regions of India today conferred the
prestigious Asia’s Emerging Pharmaceutical Company on Innovations Award 2013 in
a power packed gatherings of the industry captains. The Department of Science
& Technology, Ministry of Science & Technology was the co-sponsor of
the Event.
Speaking on the Award from Dr. S. N.
Khan, Director, Department Of Science And Technology. Govt of India
, Dr. Kannan Vishwanath, Vice Chairman &
Managing Director of Aanjaneya Lifecare Limited said “This is a rare
distinction & has a significant bearing on all our future initiatives, as a
Corporate Entity & a responsible Company, our responsibility will increase
manifold as we have wide & bigger plans ahead which we plan to achieve in
the first quarter of this year. This recognition reflects our overall
commitment to adhere quality norms, corporate ethics,investor relations besides
our long bonding with internal & external stakeholders.” Aanjaneya Lifecare
will emerge out as a leading Research driven healthcare group in the worlds as
it is presently passing through a historic innovation transition, said Dr
Kannan. Shri
D.S.Rawat, Secretary General, ASSOCHAM said “ Aanjaneya Lifecare is fast making
its foothold in the healthcare space with great speed & perfection in a
short span of time, the juries looked at overall ratings in Aanjaneya
Lifecare’s commitment to society & Medical Profession”.
The event was attended by stalwarts from policy makers, CEOs, CFOs, consultants
and senior professionals from the packaging sector and allied fields. Speakers include senior government officials,
policy makers as well as leadership from the packaging industry. The Chief
Guest for the event is the Honourable President of India- Shri Pranav
Mukherjee. Padma Bhushan Dr. B. K. Rao, Chairman, Knowledge
Millennium Committee, Ex –Chairman, Sir Ganga Ram Hospital, Prof. Aaron
Ciechanover, 2004 Noble Prize Winner in Chemistry, Dr. V. M. Katoch, Secretary
(Department of Health Research) & Director General, Indian Council of
Medical Research (ICMR), Dr. H. K. Chopra Cardiologist Mool Chand Medcity, Shri
R. N. Dhoot, Member of Parliament and President, ASSOCHAM, Shri D.S.Rawat,
Secretary General, ASSOCHAM, Shri S. Jaipal Reddy, Hon’ble Minister of Science
& Technology & Earth Sciences, GoI, Dr. Rana Kapoor, Sr. Vice
President, ASSOCHAM & Founder, Managing Director and CEO, Yes Bank Ltd, Dr.
S. N. Khan, Director, Department Of Science And Technology were among those who
graced & spoke at the prestigious Event. Dr Kannan Vishwanath, Managing
Director of Aanjaneya Life care delivered a talk on Innovations in Healthcare
Industry : Challenges within & Outside at the Summit.
About Aanjaneya Lifecare Limited:
Aanjaneya
Lifecare Limited, BSE code (533412), a Rs 490 crores, integrated pharmaceutical
company engaged in the manufacture of Active Pharmaceutical Ingredients and Finished Dosage Forms along with delivery of CRAMS has
its presence in 60 countries.
The
company with its manufacturing facilities –in Mahad, Hyderabad and Pune has to
its credit many achievements.
- It is the world’s third-largest manufacturer
of quinine salts and the second-largest in India. Only nine companies
globally manufacture quinine salts. Aanjaneya is only the second company
to receive WHO prequalification for its anti-malarial APIs and
formulations.
- It is one of the most cost-effective quinine
manufacturers
- One of the largest
codeine quota holders in the pharmaceutical sector
- The only manufacturer of multi- flavored
Lozenge medical products in India
- The only company in India
to be classified as ethical prescription dosages for diverse therapeutic
segments. It is positioned as a global Centre of Excellence in the area of
Lozenge manufacture
- The company pioneered the recognition that
lozenges represent a stable platform for the delivery of pharmaceutical
and nutraceutical ingredients
- Anjaneya’s Nicco Nil lozenge is a
first-of-its-kind remedy in the world for smoking de-addition; its Relacs
is a first-time lozenge against insomnia in India, and Arecta Plus, a
lozenge variant for Viagra, is a first for India.
The
company has an expertise in opportunity spotting and innovation. The company’s
success has been built on a business model that integrates Research, Innovation
and Knowledge. The company has invested in building proprietary Knowledge
through research and acquisitions.
Anajaneyas
Lifecare’s competence has been validated through patents granted by
international and Indian authorities.
Highlights
2011-2012 for Active Pharmaceutical Ingredents
- Production of Quinine
Sulphate increased 30% in 2011-2012
- Sales of Quinine Sulphate
grew 45%
- Exports increased 250% from
Rs 10 Crore to Rs 31 crore
- Added 35 international and
50 domestic clients
- Completed trials for
Bromexine(expectorant)a new API that will be launched in 2012-1023
Highlights
2011-2012 for Finished Dosage Forms
- Launched 'Rancorex' an
in-house codine based cough syrup brand for the first time in its history
- received the Kenya PPB GMP
approval from all facilities namely lozenges,liquids and iontments
- Received registration for
'Arecta Plus'(a lozenge variant of Viagra tablets)from Sierrs Leone and
Libya; received the first export order for this product to be executed in
2012-2013
Aanjaneya
Lifecare Limited, a vertically integrated pharmaceutical company with
manufacturing and marketing capabilities in APIs (Active Pharmaceutical
Ingredients) with focus on anti-malarial, and finished dosage forms (FDFs)
catering to various therapeutic segments.The company is the third largest
Quinine Salts manufacturer in the world.The company recently raised about Rs.
117 crore from its IPO and the funds are being used to built new capacities
along with the refurbishing of Research & Development centre. The new
facilities being created as part of CAPEX are using eco friendly, recyclable
material and will be rated by LEEDS once completed, company sources informed.
The Facilities being established will comply with the latest European & US
guidelines. With new capacities to be added in next 6 to 9 months the company
will be expanding operations in emerging markets of South East Asia, Africa
& South & Central America and its domestic operation in branded
generics segment. Landmark Awards for Aanjaneya Lifecare Ltd.
1. India's Most technically &
scientifically advanced Pharmaceutical Manufacturing unit of the year 2011 at
4th Annual Pharmaceutical Leadership Summit & Business Leadership Awards
2011
2. Emerging Company of the Year 2011 at 4th
Annual Pharmaceutical Leadership Summit & Business Leadership Awards 2011
3. Gold Certification for its Annual Report
at the LACP 2012 Global Communications Spotlight Awards Held in Florida USA
4. India’s Most Valuable Company on
“Corporate Governance, Ethical Practice & Sustainability Vision” Award at
3rd Annual India Leadership Conclave & Business Leadership Awards 2012.
5. ‘IMC Ramakarishna Bajaj Award 2012’. one
of the most prestigious Quality awards in India. The company got recognised as
one of the leading and fastest growing integrated pharma companies in India.
6. BSE Award for Best Return to Investors
2012 at 5th Annual Pharmaceutical Leadership Summit & Business Leadership
Awards 2012.
7. Aanjaneya Lifecare Limited ranked No 2
Industry wise & 9th Position in the Asia- Pacific region at The Global
Investor Relations Summit.
This was a really interesting article, thanks for sharing it. Packaging is used worldwide and is imperative for most products. Packaging industry engineers can help produce the right packaging for these products. Thanks again.
ReplyDelete